Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Price, Quote & News

Company Profile

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

StocktwitsNews Jul. 31 at 1:36 PM

NVO Stock Slumps After Late-Stage Trial Fails Primary Goal – Retail Says ‘Current Revenue Drivers’ Still Intact $NVO $OZEM https://stocktwits.com/news/equity/markets/nvo-stock-slumps-after-late-stage-trial-fails-primary-goal-retail-says-current-revenue-drivers-still-intact/cZN4B0qRJPh

0 · Reply

getshorty77 Jul. 28 at 2:34 PM

$OZEM New to this. Is there truly a benefit to owning it over the best pharma brand producing them?

1 · Reply

StocktwitsNews Jul. 24 at 10:50 AM

Novo Nordisk Reportedly Escalates Legal Battle Against Eli Lilly – Even As Analysts See LLY Leading The GLP-1 Race $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-reportedly-escalates-legal-battle-against-eli-lilly-even-as-analysts-see-lly-leading-the-glp-1-race/cZZYsGBR7y1

0 · Reply

StocktwitsNews Jul. 23 at 12:23 PM

Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing $LLY $NVO $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-moves-closer-to-another-weight-loss-drug-retatrutide-clears-two-more-phase-3-trials-ahead-of-fda-filing/cZZnFXJR7xA

0 · Reply

Makingmillions192 Jul. 14 at 1:54 PM

$OZEM $THNR $HRTS While Big Pharma races to acquire oral GLP-1 delivery tech, this platform developer is about to drop human and next-gen animal datasets that could rewrite the market's tolerability standards. The Late-Summer Data Drop Schedule: Lexaria Bioscience: NASDAQ: LEXX Mid-August 2026 | Animal Study #2 (GLP-1-A26-2) Pharma is watching platform compatibility and PK data for tomorrow's next-gen blockbusters: Eli Lilly's retatrutide and Novo Nordisk's amycretin. Late August / Early September 2026 | Human Study #7 (GLP-1-H26-7) THE MAIN EVENT. Head-to-head 5-week steady-state human data comparing DehydraTECH-semaglutide tablets directly against Wegovy. Pharma is tracking bio-absorption and a projected ~40% reduction in GI side effects. Early September 2026 | Animal Study #1 (GLP-1-A26-1) Pharma is watching alternative novel formulations designed to bypass or improve upon traditional, erratic SNAC-inclusive carriers.

0 · Reply

TheArtOfFinancialWar Jul. 7 at 2:28 PM

$OZEM HINT: target ozempic mass tort / bio pharma case and win billions 💰🪭🔥 out of 100 top plaintiff law firms investments of equity if only 1-2 succeed that’s a MASSIVE return on investment 😻 more than decades of investing in $SPY @mhparvez @TaoistTrader @LetsGoMets107 @Khalifha @PaPaBaZi @blancoBull @sonicmerlin

2 · Reply

JFDI Jul. 1 at 1:08 PM

$OZEM gap n go

1 · Reply

StocktwitsNews Jun. 17 at 12:04 PM

HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth Catalyst $HIMS $OZEM https://stocktwits.com/news/equity/markets/hims-stock-breakout-peptides-glp1-growth/cZK0wLiR7IV

0 · Reply

StocktwitsNews Jun. 15 at 5:56 PM

HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout? $HIMS $EDOC $OZEM https://stocktwits.com/news/equity/markets/hims-stock-gains-eyes-on-breakout/cZKfp1LR73n

0 · Reply

StocktwitsNews Jun. 8 at 10:32 AM

LLY Stock Heads To Record High – Here’s Why Retail’s Bullish On Latest GLP-1 Data $LLY $OZEM https://stocktwits.com/news/equity/markets/lly-stock-heads-to-record-high-heres-why/cZ0vRnLR7G2

0 · Reply

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

ABBV ALKS AMGN GILD IBB IHE JNJ

Sep 12, 2024, 2:51 PM EDT - 2 years ago

Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

CHAT MAGS

Jun 24, 2024, 7:35 PM EDT - 2 years ago

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

THNR

May 29, 2024, 12:01 PM EDT - 2 years ago

OZEM: Investing in the Weight Loss Craze

May 27, 2024, 12:01 PM EDT - 2 years ago

This new weight loss drug ETF bets big on two of the industry's leading players

May 21, 2024, 5:02 PM EDT - 2 years ago

New funds jump on weight loss trade

May 21, 2024, 9:00 AM EDT - 2 years ago

Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)

May 20, 2024, 1:40 PM EDT - 2 years ago

Roundhill to launch active weight loss ETF

StocktwitsNews Jul. 31 at 1:36 PM

0 · Reply

getshorty77 Jul. 28 at 2:34 PM

$OZEM New to this. Is there truly a benefit to owning it over the best pharma brand producing them?

1 · Reply

StocktwitsNews Jul. 24 at 10:50 AM

0 · Reply

StocktwitsNews Jul. 23 at 12:23 PM

0 · Reply

Makingmillions192 Jul. 14 at 1:54 PM

0 · Reply

TheArtOfFinancialWar Jul. 7 at 2:28 PM

2 · Reply

JFDI Jul. 1 at 1:08 PM

$OZEM gap n go

1 · Reply

StocktwitsNews Jun. 17 at 12:04 PM

0 · Reply

StocktwitsNews Jun. 15 at 5:56 PM

HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout? $HIMS $EDOC $OZEM https://stocktwits.com/news/equity/markets/hims-stock-gains-eyes-on-breakout/cZKfp1LR73n

0 · Reply

StocktwitsNews Jun. 8 at 10:32 AM

LLY Stock Heads To Record High – Here’s Why Retail’s Bullish On Latest GLP-1 Data $LLY $OZEM https://stocktwits.com/news/equity/markets/lly-stock-heads-to-record-high-heres-why/cZ0vRnLR7G2

0 · Reply

daytradederic Jun. 5 at 1:02 PM

$OZEM looks like the ETF wants to finally break out.

0 · Reply

StocktwitsNews Jun. 5 at 12:53 PM

TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant $LLY $OZEM $NVO $HIMS https://stocktwits.com/news/equity/markets/td-cowen-glp1-sales-forecast-lilly-novo-to-remain-leaders/cZ0FkzQReCB

0 · Reply

Academia Jun. 3 at 1:51 PM

$SPY $QQQ $NVO $OZEM If you're on a GLP1 with the only purpose to lose a small amount of body fat....

1 · Reply

BillionerOfKing May. 4 at 6:39 PM

$OZEM Current Stock Price: $31.40 Contracts to trade: $26.0 OZEM May 15 2026 Call Entry: $5.10 Exit: $9.38 ROI: 84% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Tankman22 Apr. 14 at 11:40 AM

$RKTO easy buy to north!!! Obesity is one of the worlds issues… buy up bulls to 1$ 🔥‼️ $SLNH $OZEM $IBRX $UAVS

0 · Reply

StocktwitsNews Mar. 21 at 6:29 PM

Glenmark Debuts Budget Semaglutide In India, Undercutting Ozempic By Over 80% $GLENMARK.NSE $OZEM $LLY $NVO https://stocktwits.com/news/equity/markets/glenmark-debuts-budget-semaglutide-in-india/cZ3i3maRIih

0 · Reply

StocktwitsNews Feb. 26 at 12:04 PM

Eli Lilly’s Diabetes Pill Outperforms Oral Semaglutide in Phase 3 Trial $LLY $OZEM https://stocktwits.com/news/equity/markets/eli-lilly-oral-glp1-orforglipron-beats-semaglutide-phase-3-trials/cZTG90fRIbo

0 · Reply

StocktwitsNews Feb. 25 at 1:29 PM

Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes $NVO $LLY $OZEM $THNR $PPH https://stocktwits.com/news/equity/markets/novo-vivtex-deal-to-develop-oral-medicines-for-obesity-diabetes/cZRydmtRIGP

0 · Reply

StocktwitsNews Feb. 12 at 10:21 AM

Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report $NVO $OZEM $PPH https://stocktwits.com/news/equity/markets/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc

0 · Reply

StocktwitsNews Feb. 10 at 2:59 PM

Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial $RKTO $HIMS $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/hoth-therapeutics-gdnf-treatment-shows-superior-efficacy-over-wegovy-ozempic-in-preclinical-trial/cZbUJr3R4p2

0 · Reply

Market Cap	N/A
Revenue (ttm)	N/A
Net Income (ttm)	N/A
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	14,604
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	N/A
Price Target	N/A